Literature DB >> 31435196

Statins and Hepatocellular Carcinoma Protection.

David E Kaplan1.   

Abstract

Entities:  

Year:  2019        PMID： 31435196      PMCID： PMC6696599     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.

Authors:  Takaaki Higashi; Hiromitsu Hayashi; Yuki Kitano; Kensuke Yamamura; Takayoshi Kaida; Kota Arima; Katsunobu Taki; Shigeki Nakagawa; Hirohisa Okabe; Hidetoshi Nitta; Katsunori Imai; Daisuke Hashimoto; Akira Chikamoto; Toru Beppu; Hideo Baba
Journal:  Med Oncol       Date:  2016-10-12       Impact factor: 3.064

2.  Statin use and risk of hepatocellular carcinoma in a U.S. population.

Authors:  Katherine A McGlynn; George W Divine; Vikrant V Sahasrabuddhe; Lawrence S Engel; Ashley VanSlooten; Karen Wells; Marianne Ulcickas Yood; Sharon Hensley Alford
Journal:  Cancer Epidemiol       Date:  2014-08-10       Impact factor: 2.984

3.  Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.

Authors:  John Chen Hsiang; Grace Lai-Hung Wong; Yee-Kit Tse; Vincent Wai-Sun Wong; Terry Cheuk-Fung Yip; Henry Lik-Yuen Chan
Journal:  J Hepatol       Date:  2015-07-21       Impact factor: 25.083

4.  Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.

Authors:  Hashem B El-Serag; Michael L Johnson; Christine Hachem; Robert O Morgana
Journal:  Gastroenterology       Date:  2009-01-30       Impact factor: 22.682

5.  Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

Authors:  David E Kaplan; Marina A Serper; Rajni Mehta; Rena Fox; Binu John; Ayse Aytaman; Michelle Baytarian; Kristel Hunt; Jeffrey Albrecht; Basile Njei; Tamar H Taddei
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

6.  Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.

Authors:  Juan G Abraldes; Candid Villanueva; Carles Aracil; Juan Turnes; Manuel Hernandez-Guerra; Joan Genesca; Manuel Rodriguez; Jose Castellote; Juan Carlos García-Pagán; Ferran Torres; Jose Luis Calleja; Agustin Albillos; Jaime Bosch
Journal:  Gastroenterology       Date:  2016-01-14       Impact factor: 22.682
  6 in total
  1 in total

1.  Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.

Authors:  Elias Khajeh; Arash Dooghaie Moghadam; Pegah Eslami; Sadeq Ali-Hasan-Al-Saegh; Ali Ramouz; Saeed Shafiei; Omid Ghamarnejad; Sepehr Abbasi Dezfouli; Christian Rupp; Christoph Springfeld; Carlos Carvalho; Pascal Probst; Seyed Mostafa Mousavizadeh; Arianeb Mehrabi
Journal:  BMC Cancer       Date:  2022-01-21       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.